AccoladeACCD
Market Cap: 326M
About: Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
Employees: 2,400
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
6% more funds holding
Funds holding: 140 [Q4 2023] → 148 (+8) [Q1 2024]
8% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 49
0.25% more ownership
Funds ownership: 87.91% [Q4 2023] → 88.16% (+0.25%) [Q1 2024]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q4 2023] → 4 (+0) [Q1 2024]
11% less capital invested
Capital invested by funds: $804M [Q4 2023] → $715M (-$88.4M) [Q1 2024]
78% less call options, than puts
Call options by funds: $3.86M | Put options by funds: $17.6M
Research analyst outlook
17 Wall Street Analysts provided 1 year price forecasts over the past 6 months
17 analyst ratings
Guggenheim Sandy Draper | 47%upside $6 | Buy Maintained | 28 Jun 2024 |
Stifel David Grossman | 96%upside $8 | Buy Maintained | 28 Jun 2024 |
Truist Securities Jailendra Singh | 121%upside $9 | Buy Maintained | 28 Jun 2024 |
Morgan Stanley Ricky Goldwasser | 47%upside $6 | Equal-Weight Maintained | 28 Jun 2024 |
Barclays Stephanie Davis | 35%upside $5.5 | Equal-Weight Maintained | 28 Jun 2024 |
Financial journalist opinion
Based on 61 articles about ACCD published over the past 30 days